NCT03492931 - PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 28, 2018

Primary Completion Date

May 7, 2019

Study Completion Date

May 7, 2019

Conditions

Sickle Cell Disease

Interventions

DRUG

Ticagrelor

Patients will receive a single dose of ticagrelor

Trial Locations (8)

Research Site, Tripoli

Research Site, Edegem

Research Site, Genova

Research Site, Madrid

Research Site, Kisumu

Research Site, Nairobi

Research Site, Beirut

Research Site, London